AstraZeneca to invest $50 bil in U.S. amid tariff threat
AstraZeneca plans to invest USD 50 bil in U.S. by 2030 to expand drug manufacturing and research, responding to proposed tariffs on drug imports under the Trump administration.
22/07/2025 14:07 MYT
Episode
More Videos